This may be attributable, in part, to the ability of HIF-1α to upregulate inflammatory signalling via nuclear factor-κB, which is upregulated in a dose-dependent response with disease severity in OSA patients [84,85]. This evidence concerns the gene HIF1A and obstructive sleep apnea syndrome.